These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1752347)

  • 61. Natural course of insulin sensitivity and insulin reserve in early insulin-dependent diabetes mellitus.
    Linn T; Ebener K; Raptis G; Laube H; Federlin K
    Metabolism; 1995 May; 44(5):617-23. PubMed ID: 7752910
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Appearance of islet cell autoantibodies after clinical diagnosis of diabetes mellitus.
    Landin-Olsson M; Arnqvist HJ; Blohmé G; Littorin B; Lithner F; Nyström L; Scherstén B; Sundkvist G; Wibell L; Ostman J; Lernmark A
    Autoimmunity; 1999; 29(1):57-63. PubMed ID: 10052686
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Relationship between urinary neopterin excretion and islet cell antibodies in type 1 (insulin-dependent) diabetes.
    Manna R; Salvatore M; Di Leo MA; Scuderi F; Greco AV; Ghirlanda G; Gambassi G
    Diabetes Res; 1991 May; 17(1):33-6. PubMed ID: 1816978
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Slowly progressing type 1 diabetes: persistence of islet cell autoantibodies is related to glibenclamide treatment.
    Cabrera-Rode E; Perich P; Diaz-Horta O; Tiberti C; Molina G; Arranz C; Martin JM; Licea M; De Leiva AD; Puig-Domingo M; Dimario U
    Autoimmunity; 2002 Nov; 35(7):469-74. PubMed ID: 12685875
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Detection of islet cell surface antibodies using cloned beta cells and comparison of their incidence with that of islet cell cytoplasmic antibodies.
    Grant AM; Harrison DE; Moysey L; Smith D; Ashcroft SJ
    Diabetes Res; 1985 Sep; 2(5):225-9. PubMed ID: 3905186
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Factors influencing the magnitude, duration, and rate of fall of B-cell function in type 1 (insulin-dependent) diabetic children followed for two years from their clinical diagnosis.
    Wallensteen M; Dahlquist G; Persson B; Landin-Olsson M; Lernmark A; Sundkvist G; Thalme B
    Diabetologia; 1988 Sep; 31(9):664-9. PubMed ID: 3069534
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Metabolic effect of islet B-cell function in insulin-treated diabetes.
    Gjessing HJ; Matzen LE; Iversen S; Faber OK; Frøland A
    Scand J Clin Lab Invest; 1989 Jun; 49(4):337-43. PubMed ID: 2662383
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Increased frequency of islet cell antibodies in unaffected brothers of children with type 1 diabetes.
    Eskola V; Vähäsalo P; Akerblom HK; Knip M;
    Horm Res; 2003; 59(4):195-200. PubMed ID: 12649574
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Types of pediatric diabetes mellitus defined by anti-islet autoimmunity and random C-peptide at diagnosis.
    Redondo MJ; Rodriguez LM; Escalante M; Smith EO; Balasubramanyam A; Haymond MW
    Pediatr Diabetes; 2013 Aug; 14(5):333-40. PubMed ID: 23458188
    [TBL] [Abstract][Full Text] [Related]  

  • 70. GAD antibodies in NIDDM. Ten-year follow-up from the diagnosis.
    Niskanen LK; Tuomi T; Karjalainen J; Groop LC; Uusitupa MI
    Diabetes Care; 1995 Dec; 18(12):1557-65. PubMed ID: 8722051
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Combinations of beta cell specific autoantibodies at diagnosis of diabetes in young adults reflects different courses of beta cell damage.
    Törn C; Landin-Olsson M; Lernmark A; Scherstén B; Ostman J; Arnqvist HJ; Björk E; Blohmé G; Bolinder J; Eriksson J; Littorin B; Nyström L; Sundkvist G
    Autoimmunity; 2001; 33(2):115-20. PubMed ID: 11264790
    [TBL] [Abstract][Full Text] [Related]  

  • 72. CRP and IL-6 concentrations are associated with poor glycemic control despite preserved beta-cell function during the first year after diagnosis of type 1 diabetes.
    Schölin A; Siegbahn A; Lind L; Berne C; Sundkvist G; Björk E; Karlsson FA;
    Diabetes Metab Res Rev; 2004; 20(3):205-10. PubMed ID: 15133751
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Diazoxide treatment at onset preserves residual insulin secretion in adults with autoimmune diabetes.
    Björk E; Berne C; Kämpe O; Wibell L; Oskarsson P; Karlsson FA
    Diabetes; 1996 Oct; 45(10):1427-30. PubMed ID: 8826981
    [TBL] [Abstract][Full Text] [Related]  

  • 74. No effect of oral insulin on residual beta-cell function in recent-onset type I diabetes (the IMDIAB VII). IMDIAB Group.
    Pozzilli P; Pitocco D; Visalli N; Cavallo MG; Buzzetti R; Crinò A; Spera S; Suraci C; Multari G; Cervoni M; Manca Bitti ML; Matteoli MC; Marietti G; Ferrazzoli F; Cassone Faldetta MR; Giordano C; Sbriglia M; Sarugeri E; Ghirlanda G
    Diabetologia; 2000 Aug; 43(8):1000-4. PubMed ID: 10990077
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [The influence of clinical presentation and metabolic control of insulin dependent diabetes in the evolution of residual insulin secretion. A prospective study at five years].
    Fernández Castañer M; Gonzálbez J; Carrera MJ; Nacher V; Montanya E; Abós R; Soler J
    Med Clin (Barc); 1997 Sep; 109(9):328-32. PubMed ID: 9379763
    [TBL] [Abstract][Full Text] [Related]  

  • 76. B-cell responses to intravenous glucose and glucagon in non-diabetic twins of patients with type 1 (insulin-dependent) diabetes mellitus.
    Heaton DA; Lazarus NR; Pyke DA; Leslie RD
    Diabetologia; 1989 Nov; 32(11):814-7. PubMed ID: 2687066
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Different effects of duration on prevalence of anti-adrenal medullary and pancreatic islet cell antibodies in type I diabetes mellitus.
    Brown FM; Vinik AI; Ganda OP; Adri MN; Rabinowe SL
    Horm Metab Res; 1989 Aug; 21(8):434-7. PubMed ID: 2676819
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Islet cell antibodies in insulin-dependent (type 1) diabetic children treated with plasmapheresis.
    Marner B; Lernmark A; Ludvigsson J; MacKay P; Matsuba I; Nerup J; Rabinovitch A
    Diabetes Res; 1985 Sep; 2(5):231-6. PubMed ID: 3905187
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Islet cell antibodies identify latent type I diabetes in patients aged 35-75 years at diagnosis.
    Groop LC; Bottazzo GF; Doniach D
    Diabetes; 1986 Feb; 35(2):237-41. PubMed ID: 3510930
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Relation between insulin antibody and complement-fixing islet cell antibody at clinical diagnosis of IDDM.
    Karjalainen J; Knip M; Mustonen A; Ilonen J; Akerblom HK
    Diabetes; 1986 May; 35(5):620-2. PubMed ID: 3514336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.